Orient Pharma Co., Ltd.
6 clinical trials · Sponsor
◉ Watch Orient Pharma Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Compare the Efficacy and Safety of 1PC111 With Pitavastatin and Ezetimibe in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia (NCT04643093) | Orient Pharma Co., Ltd. | 2020-08-01 |
| Evaluate Long-term Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD (NCT02704390) | Orient Pharma Co., Ltd. | 2016-01-01 |
| Evaluate Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD (NCT02450890) | Orient Pharma Co., Ltd. | 2015-06-01 |
| Efficacy of HUEXC030 in Subjects With Pulmonary Tuberculosis (NCT02467608) | Orient Pharma Co., Ltd. | 2012-12-06 |
| Efficacy and Safety Study of Pitavastatin for Hypercholesterolemia (NCT01710007) | Orient Pharma Co., Ltd. | 2011-11-01 |
| A Relative Efficacy and Safety Study of OC Oral Solution for Sialorrhoea in Patients With Parkinson's Disease (NCT01370811) | Orient Pharma Co., Ltd. | 2011-08-01 |
Track Orient Pharma Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.